BiotechTube
Home/Kaerus Bioscience/Valentin Gribkoff
VG

Valentin Gribkoff

Ion Channel Pharmacology

Kaerus Bioscience

Therapeutic Areas

Neurodevelopmental DisordersRare Genetic Diseases

Kaerus Bioscience Pipeline

DrugIndicationPhase
KER-0193Fragile X syndromePreclinical
BK Channel ModulatorKCNMA1-linked ChannelopathiesPreclinical

Leadership Team at Kaerus Bioscience

RH
Robert H. Ring
Chief Executive Officer
MC
Marc Ceusters
Head of Development
NS
Nicholas Stern
Chief Financial Officer
View full Kaerus Bioscience profile